Close
Almac
Achema middle east

Full CPhI & Pharmapack Europe schedule returns in 2021 with live & hybrid events

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

First GLP-1 Pill for Obesity by Novo Nordisk Approved by FDA

The U.S. Food and Drug Administration – FDA on...

How High-Achievers Stay Future-Ready in Evolving Job Markets

Job markets today are transforming rapidly. In the past...

Proactive Risk Management as a Core Capability in Pharma Development

Risk management in pharma is often treated as a reactive compliance box-ticking exercise. This article argues for reframing risk as a strategic competitive advantage. It details proactive frameworks like the "Excipient Exclusion Filter," Decision Quality (DQ) matrices, and "pre-mortem" analyses that allow development teams to anticipate failure modes and engineer them out of the pipeline before they occur.
- Advertisement -

Informa Markets announces its complete listing of pharma event dates for 2021 at the opening of the first CPhI Festival of Pharma (05 – 16 October 2020) – the largest ever virtual pharma event.

The pharma schedule includes one further event in 2020: CPhI China, 16-18 December (hybrid event, combining “live” in-person with “virtual”). In 2021, all eight international CPhI editions [Worldwide, India, China, North America, Middle East & Africa, South East Asia, Korea and Japan] will return in full along with Pharmapack Europe.

The 2021 events will be enhanced by digital elements, providing greater networking and learning opportunities to the global pharma industry, with the complete pharma portfolio resuming late spring onwards.

“We are thrilled about coming together with the pharma community again at CPhI Festival of Pharma, and we wanted to give details of all our pharma events for the year ahead. In 2021 we are implementing a hybrid model of events delivery, with virtual and online offerings, as well as live editions to provide greater flexibility to pharma companies and executives” commented Adam Andersen, Group Director of the Pharma Portfolio at Informa Markets.

Confirmed pharma event dates

16-18 December 2020: CPhI China (hybrid, live + virtual)
27-29 January: CPhI India
14-16 April: CPhI Japan
19-20 May: Pharmapack Europe
22-24 June: CPhI China
4-6 August: CPhI SEA
10-12 August: CPhI North America
31 Aug-2 Sept: CPhI Worldwide
26-28 September: CPhI MEA
11-13 October: CPhI Korea
23-25 November: CPhI India

To ensure the highest possible attendee safety, the organisers are working closely with local governments and authorities, and all future pharma events will feature the Informa AllSecure enhanced health and safety standards – providing the most robust at-event biosafety measures, spanning dozens of special safety protocols.

Andersen added, “Over the last 31 years, CPhI has created a unique platform to unite specialist communities dedicated to improving healthcare. We provide a place where professionals can meet, exchange knowledge and do business. But it’s the real-world impact of their work that inspires us to continually adapt our offering to meet their needs. So while our events are tailored to regional requirements, their reach and significance to patients is truly global.”

Additionally, the CPhI team will continue to empower the industry with the highest quality digital content, created in collaboration with some of the industry’s leading experts. The CPhI online platforms, CPhI-Online.com and the new Globalpharmainsights.com provide the pharma community with webinars, virtual events, analysis reports, articles and more to network and stay and informed 365 days per year.

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, South East Asia, North America, and the Middle East and Africa. Co-locating with ICSE for contract services; P-MEC for machinery, equipment & technology; InnoPack for pharmaceutical packaging; bioLIVE for biopharma; Finished Dosage Formulation for every aspect of the finished dosage supply chain; and NEX for natural extract products, applications and solutions.

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organizer, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year.

Latest stories

Related stories

First GLP-1 Pill for Obesity by Novo Nordisk Approved by FDA

The U.S. Food and Drug Administration – FDA on...

How High-Achievers Stay Future-Ready in Evolving Job Markets

Job markets today are transforming rapidly. In the past...

Proactive Risk Management as a Core Capability in Pharma Development

Risk management in pharma is often treated as a reactive compliance box-ticking exercise. This article argues for reframing risk as a strategic competitive advantage. It details proactive frameworks like the "Excipient Exclusion Filter," Decision Quality (DQ) matrices, and "pre-mortem" analyses that allow development teams to anticipate failure modes and engineer them out of the pipeline before they occur.

Rethinking Pipeline Value Beyond Peak Sales Forecasts

The traditional reliance on risk-adjusted Net Present Value (rNPV) and peak sales forecasts is failing to capture the true potential of modern pharmaceutical assets, particularly platform technologies. This article introduces holistic valuation frameworks like Real Options Analysis (ROA) and the Platform VISTA model, arguing for a shift toward valuing "strategic fit," "lifecycle potential," and the intangible equity of innovation engines.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »